Section 8: Lumecca Treatment Information
IPL Lumecca treatment is based on principles of selective photothermolysis. The light
penetrates into the skin and is selectively absorbed by lesion chromophore (melanin
or hemoglobin) having darker color than surrounding tissue. Absorbed energy is
converted into heat, coagulating the lesion which fades during a few weeks following
the treatment. Fine textural lesions like macro-pores, and fine lines may improve
along with the pigmented and vascular lesions in the skin photo-rejuvenation
process. Multiple treatment sessions may be required for best results.
8.1 Indications for Use
The Lumecca Handpieces are intended for treatment of superficial vascular and
pigmented lesions on skin type I to IV
8.2 Contraindications
▪ Current or history of skin cancer, or current condition of any other type of
cancer, or pre-malignant moles.
▪ Pregnancy and nursing.
▪ Impaired immune system due to immunosuppressive diseases such as AIDS and
HIV or use of immunosuppressive medications.
▪ Patients with history of diseases stimulated by heat, such as recurrent Herpes
Simplex in the treatment area, may be treated only following a prophylactic
regimen.
▪ Severe concurrent conditions, such as cardiac disorders, sensory disturbances.
▪ Any active condition in the treatment area, such as sores, psoriasis, eczema, and
rash.
▪ History of skin disorders, keloids, abnormal wound healing, as well as very dry
and fragile skin.
▪ Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction
and hormonal virilization.
▪ Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
▪ Certain delay is recommended if other recent treatments such as light, laser or
RF were performed on treated area.
▪ Known skin photosensitivity or using drugs increasing skin photosensitivity.
To Next Page
Loading...
